Skip to main content

Table 5 Causes of premature termination of the Radium-223 therapy

From: Application of the HTA Core Model for complex evaluation of the effectiveness and quality of Radium-223 treatment in patients with metastatic castration resistant prostate cancer

Patient

Number of Radium-223 injections applied

Number of patients

The cause of a premature treatment termination

1

5 injections

5 patients

brain metastases

2

patient refused the treatment

3

patient refused the treatment

4

progression of the overall condition

5

patient refused the treatment

6

4 injections

3 patients

progression of the overall condition

7

progression of the overall condition

8

neutropenia

9

3 injections

4 patients

progression of the overall condition

10

not identified

11

progression of the overall condition

12

patient stopped walking

13

2 injections

4 patients

anemia and thrombocytopenia

14

brain metastases

15

renal failure

16

progression of the overall condition

17

1 injection

3 patients

brain metastases

18

progression of the overall condition

19

head injury

  1. Source: Own processing